KALI INC (OTCMKTS:KALY) Shorts Declined By 74.06% As Of Mar 25, 2019

It was registered a decrease on KALI INC (OTCMKTS:KALY)’s shares shorted with 74.06%. In March was issued KALY’s total 73,700 shares shorted by FINRA. That’s 74.06% down from 284,100 shares.

KALY reached $0.012 during the last trading session after $0.0039 change.Currently Kali, Inc. is after 0.00% change in last March 25, 2018. KALY has also shares volume. The stock underperformed the S&P500 by 4.37%.

Kali, Inc. designs, markets, and distributes apparel and related products for 20-45 years old men under the VLOV brand name in the People's Republic of China.The company has $13.40 million market cap. The firm sells its products to its distributors; and directly to consumers.Last it reported negative earnings. As of March 31, 2013, it operated 17 stores in Fujian Province; and sold its products through distributors at 404 points of sale in northern, central, and southern China.

For more Kali, Inc. (OTCMKTS:KALY) news released recently go to: Globenewswire.com, Prnewswire.com, Globenewswire.com, Nasdaq.com or Globenewswire.com. The titles are as follows: “KALY – Kali-Extracts COPD Research Targeting $14 Billion Treatment Market To Be Featured In Online Corporate Update Next Week – GlobeNewswire” released on January 25, 2019, “OTC Markets Group Announces Lists of Compliance Downgrades and Caveat Emptor Designations for the Month of December – PRNewswire” on January 04, 2019, “KALY – Kali-Extracts Analyst Research Report Featuring New Cannabis Biotechnology Business Set For Release Tomorrow – GlobeNewswire” with a publish date: January 07, 2019, “PURA – Puration 2018 Sales Exceed $1 Million Goal With 2019 Goal Set At $5 Million and NOUV Dividend Coming Sooner Than Planned – Nasdaq” and the last “KALY – Kali-Extracts Updates OTCMarkets Filings and Engages Goldman Small Cap Research – GlobeNewswire” with publication date: December 18, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.